Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent <i>Clostridioides difficile</i> infection and beyond: the contribution of gut microbial-derived metabolites
Laura Martínez-Gili, Julie A. K. McDonald, Zhigang Liu, Dina Kao, Jessica R. Allegretti, Tanya Monaghan, Grace F. Barker, Jesús Miguéns Blanco, Horace R. Williams, Elaine Holmes, Mark Thursz, Julian R. Marchesi, Benjamin H. Mullish
Abstract
, we first present an overview of these recent advancements in this field, and then describe additional novel data from our laboratory on the impact of FMT for rCDI upon several gut microbial-derived metabolites which had not previously been implicated as being of relevance.
Topics & Concepts
ClostridioidesBiologyFecal bacteriotherapyGut floraMetaboliteBile acidMicrobiologyFidaxomicinClostridium difficileAntibioticsImmunologyBacteriaVancomycinBiochemistryStaphylococcus aureusGeneticsClostridium difficile and Clostridium perfringens researchGut microbiota and healthGastrointestinal motility and disorders